S1. B-factors of the V5 domain from PKCβII, a conventional PKC isoform. Figure S1 . The B-factors of Cα atoms extracted from the crystal structures of isolated PKCβII catalytic domain (2I0E [1] ) and the PKCβII intermediate (3PFQ [2] ). The residues corresponding to the C-terminal V5 domain (609-669) are shaded. V5 has elevated B-factors in both structures, indicating some degree of either static or dynamic disorder.
S2. Cloning and purification protocol for the V5α constructs.
V5α (residues 606-672 of Protein Kinase Cα, M. musculus) was cloned into a pET31b(+) vector (Novagen) as a C-terminal fusion with ketosteroid isomerase (KSI) using the following protocol. A codon-optimized DNA sequence of V5α in a pUC57 vector was obtained from Genscript. Two identical AlwNI restriction sites with Met codons, 5'-CAGATGCTG-V5α-CAGATGCTG-3', were engineered into the sequence. In addition, C619S mutation was introduced into the gene to prevent V5α dimerization via the formation of disulfide bonds. The source plasmid, pUC57, was digested with the AlwNI restriction enzyme (NEB) at 37 °C for 4 hours. The DNA fragment containing V5α was purified from the 2% agarose gel using the Gel Extraction Kit (Qiagen). The target vector, pET31b(+), was linearized by treatment with AlwNI restriction enzyme at 37 °C for 4 hours and dephosphorylated with alkaline phosphatase (NEB).
The V5α DNA insert was ligated into the pET31b(+) vector using T4 DNA ligase (NEB). As a result, the V5α sequence was placed downstream of the 125 amino acids KSI gene and upstream of a His•tag sequence. QuickChange TM protocol (Agilent Technologies) was used to (i) delete three extra nucleotides from each AlwNI restriction site; and (ii) introduce the phosphorylationmimicking T638E/S657E mutations into the newly constructed wtV5α plasmid. In this manuscript, we refer to the T638E/S657E mutant as dmV5α. S5. dmV5α binds to DPC micelles (DPCm) and acquires partial α-helical structure. Figure S4 . dmV5α binds to DPC micelles (DPCm) and acquires partial α-helical structure. (A) Overlay of the 15 N-1 H HSQC spectra of dmV5α (green) and dmV5α/DPCm (blue) collected at 11.7 Tesla. The DPC concentration is 100 mM. The cross-peaks are labeled according to the residue identity and number. HS673 stands for homoserine lactone, which is the C-terminal residue generated upon CNBr cleavage of the (His) 6 -tag from V5α. (B) Chemical shift perturbation analysis of the dmV5α and dmV5α/DPCm pair. The chemical shift perturbation Δ was calculated based on the 1 H N , 15 N, 13 Cα, 13 Cβ and 13 CO chemical shifts. Residues having an incomplete set of chemical shifts are listed in Section S4. Purple vertical lines indicate the turn and hydrophobic motifs. The NFD motif is shaded. (C) SSP scores plotted as a function of the primary structure. Compared to the micelle-free dmV5α, the helical propensity increases for the NFD motif and the surrounding region, the region between the TM and HM, and the most Cterminal amino acid stretch. (D) CD spectra of dmV5α in the presence (blue) and absence (green) of DPC micelles. The data were collected using the Jasco J-815 CD instrument on samples containing 10 µM dmV5α, 10 mM DPC in 10 mM potassium phosphate buffer at pH 7.0.
